Contact

Expression of Factor H Binding Protein in Meningococcal Strains Can Vary at Least 15-fold and is Genetically Determined

Biagini et al., PNAS (2016) - PMID: 26888286

Product(s) used in this publication:  Specialty Peptides

Abstract:

Factor H binding protein (fHbp) is a lipoprotein of Neisseria meningitidis important for the survival of the bacterium in human blood and a component of two recently licensed vaccines against serogroup B meningococcus (MenB). Based on 866 different amino acid sequences this protein is divided into three variants or two families. Quantification of the protein is done by immunoassays such as ELISA or FACS that are susceptible to the sequence variation and expression level of the protein. Here, selected reaction monitoring mass spectrometry was used for the absolute quantification of fHbp in a large panel of strains representative of the population diversity of MenB. The analysis revealed that the level of fHbp expression can vary at least 15-fold and that variant 1 strains express significantly more protein than variant 2 or variant 3 strains. The susceptibility to complement-mediated killing correlated with the amount of protein expressed by the different meningococcal strains and this could be predicted from the nucleotide sequence of the promoter region. Finally, the absolute quantification allowed the calculation of the number of fHbp molecules per cell and to propose a mechanistic model of the engagement of C1q, the recognition component of the complement cascade.

KEYWORDS:

MenB vaccine; SRM-MS; antigen density; fHbp antigen; selected reaction monitoring mass spectrometry

Stay in touch and be the first to receive the latest news!